Eli Lilly partners with Shanghai Junshi for COVID-19 cure
U.S. pharmaceutical Eli Lilly is partnering with Chinese drugmaker Shanghai Junshi Biosciences to develop new antibody therapies for COVID-19, the...
COVID19
India and Pakistan’s ‘red zones’ keep COVID-19 trajectory on rise
MUMBAI/TOKYO -- India on Monday entered Phase 3 of the world's largest lockdown, in place since March 25. Although the...
Ads around COVID-19 work better within news media, study finds
Dive Brief: Ads related to COVID-19 often perform better when part of news programming, according to MediaScience's in-home audience survey...
Midlands is biggest victim of Covid-19 lockdown
Luxury carmaker Rolls-Royce is the only manufacturer to have resumed production so far, although the industry is gradually coming back...
this cybersecurity firm is not immune from Covid-19 but long-term prospects are good
When even a well run, well funded, well positioned business such as GB Group is noticing the effects of the...
COVID-19 in charts: Japan and Philippines dodge explosions
TOKYO -- The Philippines and India have imposed some of the strictest coronavirus containment measures in Asia. Japan has taken...
Myanmar’s ethnic conflicts obstruct COVID-19 aid to minorities
YANGON -- Myanmar's numerous unresolved ethnic insurgencies have made a cohesive national response to the global COVID-19 pandemic virtually impossible.Until...
India opts for own COVID-19 tests kits, rejecting those from China
NEW DELHI -- India is looking to double its coronavirus testing capacity to 100,000 per day by the end of May...
Soul of discretion: What’s selling in the COVID-19 pandemic?
When the COVID-19 pandemic first forced Americans to stay home, shopping was all about panic. Consumers who were used to...
How the COVID-19 pandemic is pushing brands to connect digitally
The idea to offer virtual skin consultants didn't occur to Sarah Akram until early 2020. Akram, a master esthetician and...
